Investigation of the cellular mechanism of inhibition of formyl-methionyl-leucyl-phenylalanine-induced superoxide anion generation in rat neutrophils by 2-benzyloxybenzaldehyde

Biochemical Pharmacology

Volumn 65, Issue 7, 2003, Pages 1043-1051

  Wang, Jih Pyang ^a   Chang, Ling Chu ^a   Lin, Yi Lee ^a   Hsu, Mei Feng ^b   Chang, Chiung Yun ^b   Huang, Li Jiau ^b   Kuo, Sheng Chu ^b  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

cAMP; CCY1a; Cellular free Ca2+; Phospholipase D; Rat neutrophil; Superoxide anion

Indexed keywords

2 BENZYLOXYBENZALDEHYDE; 8 (4 SULFOPHENYL)THEOPHYLLINE; 9 (TETRAHYDRO 2 FURYL)ADENINE; ADENOSINE DEAMINASE; ARACHIDONIC ACID; BENZALDEHYDE DERIVATIVE; CALCIUM ION; CYCLIC AMP; FORMYLMETHIONYLLEUCYLPHENYLALANINE; KT 5720; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL MYRISTATE; PHOSPHOLIPASE D; PROTEIN KINASE B; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUCCINIC ACID; SUPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTOOXIDATION; CALCIUM TRANSPORT; CELL FREE SYSTEM; CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0037378365     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00006-6     Document Type: Article

References (42)

1. Halliwell B., Gutteridge J.M. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 186:1990;1-85.
2. Segal A.W., Abo A. The biochemical basis of the NADPH oxidase of phagocytes. Trends Biochem. Sci. 18:1993;43-47.
3. Berridge M.J. Inositol trisphosphate and diacylglycerol: two interacting second messengers. Annu. Rev. Biochem. 56:1987;159-193.
4. Bonser R.W., Thompson N.T., Randall R.W., Garland L.G. Phospholipase D activation is functionally linked to superoxide generation in the human neutrophil. Biochem. J. 264:1989;617-620.
5. Okada T., Sakuma L., Fukui Y., Hazeki O., Ui M. Blockage of chemotactic peptide-induced stimulation of neutrophils by wortmannin as a result of selective inhibition of phosphatidylinositol 3-kinase. J. Biol. Chem. 269:1994;3563-3567.
6. Zu Y.L., Qi J., Gilchrist A., Fernandez G.A., Vazquez-Abad D., Kreutzer D.L., Huang C.K., Sha'afi R.I. p38 Mitogen-activated protein kinase activation is required for human neutrophil function triggered by TNF-α or fMLP stimulation. J. Immunol. 160:1998;1982-1989.
7. 2 receptor on human neutrophils. J. Immunol. 135:1985;1366-1371.
8. Chang C.Y., Kuo S.C., Lin Y.L., Wang J.P., Huang L.J. Benzyloxybenzaldehyde analogues as novel adenylyl cyclase activators. Bioorg. Med. Chem. Lett. 11:2001;1971-1974.
9. Wang J.P., Raung S.L., Kuo Y.H., Teng C.M. Daphnoretin-induced respiratory burst in rat neutrophils is, probably, mainly through protein kinase C activation. Eur. J. Pharmacol. 288:1995;341-348.
10. Goldberg B., Stern A. The role of the superoxide anion as a toxic species in the erythrocyte. Arch. Biochem. Biophys. 178:1977;218-225.
11. Wang J.P., Tsao L.T., Raung S.L., Hsu M.F., Kuo S.C. Inhibition by HAJ11 of respiratory burst and the involvement of protein tyrosine phosphorylation and phospholipase D activation. Br. J. Pharmacol. 120:1997;79-87.
12. 2+. Biochem. J. 269:1990;513-519.
13. Bellavite P., Serra M.C., Davoli A., Bannister J.V., Rossi F. The NADPH oxidase of guinea pig polymorphonuclear leukocytes. Properties of the deoxycholate extracted enzyme. Mol. Cell Biochem. 52:1983;17-25.
14. Cross A.R., Jones O.T. The effect of the inhibitor diphenylene iodonium on the superoxide-generating system of neutrophils. Specific labelling of a component polypeptide of the oxidase. Biochem. J. 237:1986;111-116.
15. Fredholm B.B., Persson C.G. Xanthine derivatives as adenosine receptor antagonists. Eur. J. Pharmacol. 81:1982;673-676.
16. Wang J.P., Raung S.L., Huang L.J., Kuo S.C. Involvement of cyclic AMP generation in the inhibition of respiratory burst by 2-phenyl-4-quinolone (YT-1) in rat neutrophils. Biochem. Pharmacol. 56:1998;1505-1514.
17. Kase H., Iwahashi K., Nakanishi S., Matsuda Y., Yamada K., Takahashi M., Murakata C., Sato A., Kaneko M. K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem. Biophys. Res. Commun. 142:1987;436-440.
18. Chang L.C., Wang J.P. Examination of the signal transduction pathways leading to activation of extracellular signal-regulated kinase by formyl-methionyl-leucyl-phenylalanine in rat neutrophils. FEBS Lett. 454:1999;165-168.
19. Chang L.C., Wang J.P. Activation of p38 mitogen-activated protein kinase by formyl-methionyl-leucyl-phenylalanine in rat neutrophils. Eur. J. Pharmacol. 390:2000;61-66.
20. Favata M.F., Horiuchi K.Y., Manos E.J., Daulerio A.J., Stradley D.A., Feeser W.S., Van Dyk D.E., Pitts W.J., Earl R.A., Hobbs F., Copeland R.A., Magolda R.L., Scherle P.A., Trzaskos J.M. Identification of a novel inhibitor of mitogen-activated protein kinase. J. Biol. Chem. 273:1998;18623-18632.
21. Cuenda A., Rouse J., Doza Y.N., Meier R., Cohen P., Gallagher T.F., Young P.R., Lee J.C. SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364:1995;229-233.
22. Vlahos C.J., Matter W.F., Hui K.Y., Brown R.F. A specific inhibitor of phosphatidylinositol 3-kinase: 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269:1994;5241-5248.
23. Billah M.M., Eckel S., Mullmann T.J., Egan R.W., Siegel M.I. Phosphatidylcholine hydrolysis by phospholipase D determines phosphatidate and diglyceride levels in chemotactic peptide-stimulated human neutrophils. Involvement of phosphatidate phosphohydrolase in signal transduction. J. Biol. Chem. 264:1989;17069-17077.
24. Uings I.J., Thompson N.T., Randall R.W., Spacey G.D., Bonser R.W., Hudson A.T., Garland L.G. Tyrosine phosphorylation is involved in receptor coupling to phospholipase D but not phospholipase C in the human neutrophil. Biochem. J. 281:1992;597-600.
25. Majumdar S., Kane L.H., Rossi M.W., Volpp B.D., Nauseef W.M., Korchak H.M. Protein kinase C isotypes and signal-transduction in human neutrophils: selective substrate specificity of calcium-dependent β-PKC and novel calcium-independent nPKC. Biochim. Biophys. Acta. 1176:1993;276-286.
26. phox of the neutrophil oxidase complex using the two-hybrid system. J. Biol. Chem. 270:1995;5695-5697.
27. Spisani S., Pareschi M.C., Buzzi M., Colamussi M.L., Biondi C., Traniello S., Zecchini G.P., Paradisi M.P., Torrini I., Ferretti M.E. Effect of cyclic AMP level reduction on human neutrophil responses to formylated peptides. Cell Signal. 4:1996;269-277.
28. 2 subtype. Mol. Pharmacol. 46:1994;213-220.
29. Mueller H., Montoya B., Sklar L.A. Reversal of inhibitory pathways in neutrophils by protein kinase antagonists: a rational approach to the restoration of depressed cell function? J. Leukoc. Biol. 52:1992;400-406.
30. phox by p38 and ERK but not by JNK. Arch. Biochem. Biophys. 334:1996;395-400.
31. Derijard B., Raingeaud J., Barrett T., Wu I.H., Han J., Ulevitch R.J., Davis R.J. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science. 267:1995;682-685.
32. 2+ influx following receptor activation. Trends Pharmacol. Sci. 12:1991;289-292.
33. i. Naunyn. Schmiedebergs Arch. Pharmacol. 344:1991;682-690.
34. Tilton B., Andjelkovic M., Didichenko S.A., Hemmings B.A., Thelen M. G-protein-coupled receptors and Fcγ-receptors mediate activation of Akt/protein kinase B in human phagocytes. J. Biol. Chem. 272:1997;28096-280101.
35. Alessi D.R., Andjelkovic M., Caudwell B., Cron P., Morrice N., Cohen P., Hemmings B.A. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15:1996;6541-6551.
36. Kim S., Jee K., Kim D., Koh H., Chung J. Cyclic AMP inhibits Akt activity by blocking the membrane localization of PDK1. J. Biol. Chem. 276:2001;12864-12870.
37. Exton J.H. Phospholipase D. Biochim. Biophys. Acta. 1436:1998;101-115.
38. Katayama K., Kodaki T., Nagamachi Y., Yamashita S. Cloning, differential regulation and tissue distribution of alternatively spliced isoforms of ADP-ribosylation-factor-dependent phospholipase D from rat liver. Biochem. J. 329:1998;647-652.
39. phox: evidence that phosphatidic acid may activate a novel protein kinase. J. Biol. Chem. 272:1997;15569-15578.
40. Tyagi S.R., Olson S.C., Burnham D.N., Lambeth J.D. Cyclic AMP-elevating agents block chemoattractant activation of diradylglycerol generation by inhibiting phospholipase D activation. J. Biol. Chem. 266:1991;3498-3504.
41. Planat V., Tronchere H., Record M., Ribbes G., Chap H. Involvement of vicinal dithiols in differential regulation of fMLP and phorbol ester-activated phospholipase D in stimulated human neutrophils. Biochem. Biophys. Res. Commun. 218:1996;847-853.
42. Kuribara H., Tago K., Yokozeki T., Sasaki T., Takai Y., Morii N., Narumiya S., Katada T., Kanaho Y. Synergistic activation of rat brain phospholipase D by ADP-ribosylation factor and rhoA p21, and its inhibition by Closridium botulinum C3 exoenzyme. J. Biol. Chem. 270:1995;25667-25671.